Immunoassays & Co.: Past, present, future? - A review and outlook from personal experience and involvement over the past 35 years

Clinical Laboratory

Volumn 54, Issue 11-12, 2008, Pages 423-438

  Wood, William Graham ^a  

^a INSTAND   (Germany)

Author keywords

Antibody; Antigen; Health care; History; Immunoassay; Methodology; Point of need; Point of care; Quality assessment; Trends

Indexed keywords

ANTIGEN;

ANTIGEN ANTIBODY REACTION; ANTIGEN PURIFICATION; CALCIUM METABOLISM; CHEMOLUMINESCENCE; ELECTROIMMUNOASSAY; ENDOCRINE SYSTEM EXAMINATION; ENZYME IMMUNOASSAY; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE TEST; IMMUNORADIOMETRIC ASSAY; IN VITRO STUDY; LABORATORY AUTOMATION; NEUROLOGIC EXAMINATION; NONHUMAN; QUALITY CONTROL; RADIOIMMUNOASSAY; REVIEW; STANDARDIZATION;

AFFINITY LABELS; ANTIGEN-ANTIBODY REACTIONS; AUTOMATION; CLINICAL LABORATORY TECHNIQUES; DELIVERY OF HEALTH CARE; HUMANS; IMMUNOASSAY; IMMUNOENZYME TECHNIQUES; POINT-OF-CARE SYSTEMS;

EID: 60549086565     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (166)

1. Lombard M, Pastoret PP, Moulin AM. A brief history of vaccines and vaccination. Rev Sci Tech 2007; 26: 29-48.
2. Henricy A. In: Anthony Henricy (ed.), Lady Mary Wortley Montagu, Letters of the Right Honourable Lady Mary Wortley Montagu: Written During her Travels in Europe, Asia and Africa, 1796; pp. 167-9.
3. Berson SA, Yalow RS. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest. 1959; 38: 1996-2016.
4. Yalow RS, Berson SA. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960; 39: 1157-75.
5. Ekins R.P. Estimation of protein bound 131 I in plasma. Phys Med Biol. 1959; 4: 182-4.
6. Ekins R.P. The estimation of thyroxine in human plasma by an electrophoretic technique. Clin Chim Acta. 1960; 5:453-9.
7. Berson SA, Yalow RS, Aurbach GD, Potts JT. Immunoassay of bovine and human parathyroid hormone. [My paper] Proc Natl Acad Sci U S A. 1963; 49: 613-7.
8. Odell WD, Wilber JF, Paul WE. Radioimmunoassay of thyrotropin in human serum. J Clin Endocrinol Metab. 1965; 25: 1179-88.
9. Odell WD, Ross GT, Rayford PL. Radioimmunoassay for human luteinizing hormone. [My paper] Metabolism. 1966; 15: 287-9.
10. Berson SA, Yalow RS. Radioimmunoassay of ACTH in plasma. [My paper] J Clin Invest. 1968; 47: 2725-51.
11. Odell WD, Wilber JF, Utiger RD. Studies of thyrotropin physiology by means of radioimmunoassay. Recent Prog Horm Res. 1967; 23: 47-85.
12. Ross GT, Odell WD, Rayford PL. Luteinizing hormone activity in plasma during the menstrual cycle. Science 1967; 155: 1679-80.
13. Miles LE, Hales CN, Immunoradiometric assay of human growth hormone. Lancet 1968; 2 (7566): 492-3.
14. Engvall E, Perlmann P. Enzyme-linked immununosorbent assay (ELISA) Quantitative assay of immunoglobulin G. Immunochemistry 1971; 8: 871-4.
15. Rubenstein KE, Schneider RS, Ullmann EF. "Homogeneous" enzyme immunoassay. A new immunochemical technique. Biochem Biophys Res Commun 1972; 47: 846-51.
16. Jirkalova V, Cap J, Strakova H, Pribysova J, Plicka J, Lomsky R. Immunoradiometric and luminescence immunoenzymometric assay of human thyrotropin from dried blood spots for screening of neonatal hypothyroidism Eur J Clin Chem Clin Biochem. 1996; 34: 823-7.
17. Cruickshank B, Currie AR. Localization of tissue antigens with the fluorescent antibody technique: application to human anterior pituitary hormones. Immunology. 1958; 1: 13-26.
18. Torrigiani G. Methods for the detection of auto-antibodies. Acta Allergol. 1963;18: 489-94.
19. Vavilov SI. In: Collected Papers, (in Russian) Vol 1, 1936, (Published 1954), Moscow.
20. Hemmilä I, Soini E, Lövgren T. Time-resolved fluoroimmunoassay (TR-FIA). Fresenius Z Anal Chem 1982; 311: 357.
21. Lövgren T, Pettersson K. Time-resolved fluoroimmunoassay, advantages and limitations. In: Luminescence immunoassay and molecular applications, Eds. Van-Dyke K, Van-Dyke R, CRC Press, Boca Raton, 1990; Chapter 16, 233-53. ISBN 0-8493-5865-5.
22. Hemmilä I, Harju R. Time-resolved fluorometry. In: Bioanalytical applications of labelling technologies, Eds. Hemmilä I, Ståhlberg T, Mottram P, Wallac Oy, Turku, 1994; Chapter 5, 83-119. ISBN 951-9489-29-0.
23. Sánchez-Carbayo M, Mauri M, Alfayate R, Miralles C, Soria F. Analytical and clinical evaluation of TSH and thyroid hormones by electrochemiluminescent immunoassays. Clin Biochem. 1999; 32: 395-403.
24. Pan LP, Durham B, Wolinska J, Millett F. Preparation and characterization of singly labeled ruthenium polypyridine cytochrome c derivatives. Biochemistry 1988; 27: 7 180-7.
25. Sapin R, Gasser F, d'Herbomez M, Wemeau JL, Ebert C, Schlienger JL. Elecsys thyrotropin (TSH) assay evaluated. Clin Chem. 1997; 43: 545-7.
26. Noldus J, Stamey TA Limitations of serum prostate specific antigen in predicting peripheral and transition zone cancer volumes as measured by correlation coefficients. J Urol. 1996; 155: 232-7.
27. Babson AL, Olson DR, Palmieri T, Ross AF, Becker DM, Mulqueen PJ. The IMMULITE assay tube: a new approach to heterogeneous ligand assay. Clin Chem. 1991; 37: 1521-2.
28. Lindstedt G, Himmelmann CE, Salsmans R, Valentin K. Home testing for pregnancycan it be recommended? Scand J Clin Lab Invest. 1982; 42: 371-6.
29. Hanlon JT, Caiola SM, Muhlbaier LH, Dennis BH, Edelman DA, Dingfelder JR An evaluation of the sensitivity of five home pregnancy tests to known concentrations of human chorionic gonadotropin. Am J Obstet Gynecol. 1982; 144: 778-82.
30. Jehanli A, Brannan S, Moore L, Spiehler VR. Blind trials of an onsite saliva drug test for marijuana and opiates. J Forensic Sci. 2001; 46: 1214-20.
31. Harris S, Harris TN. The measurement of neutralizing antibodies to streptococcal hyaluronidase by a turbidimetric method. J. Immunol. 1949: 63: 233-47.
32. Kreutzer HJ An immunological turbidimetric method for serum transferrin determination. J Clin Chem Clin Biochem. 1976; 14: 401-6.
33. Wood WG, Lüdemann J, Mitusch R, Heinrich J, Maass R, Frick U. Evaluation of a sensitive immunoluminometric assay for the determination of C-reactive protein (CRP) in serum and plasma and the establishment of reference ranges for different groups of subjects. Clin Lab. 2000; 46: 131-40.
34. Hartmann J. Cardiolipin antigen: nephelometric measurements. I. Acta Pathol Microbiol Scand. 1955; 36: 82-6.
35. Cambiaso CL, Riccomi HA, Masson PL, Heremans JF Automated nephelometric immunoassay II. Its application to the determination of hapten. J Immunol Methods. 1974; 5: 293-302.
36. Sugimoto H, Kuroda M, Morikawa K, Hashimoto N, Hasegawa T, Nakai T, Tamai T, Miyabo S. Latex agglutination nephelometric immunoassay for microalbuminuria - [in Japanese]. Rinsho Byori. 1987; 35: 73-9.
37. Borque L, Maside C, Iglesias A Automated turbidimetry of serum lipoprotein(a). Eur J Clin Chem Clin Biochem. 1993; 31: 869-74.
38. Simó JM, Joven J, Clivillé X, Sans T Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer. Clin Chem. 1994; 40: 625-9.
39. Schrumpf E, Sand T. Radioimmunoassay of gastrin with activated charcoal. Scand J Gastroenterol. 1972; 7: 683-7.
40. Wool MS, Selenkow HA Charcoal-dextran radioimmunoassay of human growth hormone. Acta Endocrinol (Copenh). 1968; 57: 109-14.
41. Malacara JM, Velasco E, García-Vela A. Luteinizing hormone-releasing hormone (LRH) extraction from peripheral plasma using bentonite and its measurement by radioimmunoassay during the menstrual cycle and in menopause. Rev Invest Clin. 1980; 32: 11-20.
42. Lazarus L, Young JD. Radioimmunoassay of human growth hormone using ion exchange resin. J Clin Endocrinol Metab. 1966; 26: 213-8.
43. Oliver GC Jr, Parker BM, Brasfield DL, Parker CW. The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest. 1968; 47: 1035-42.
44. Cocola F, Genazzani AR, Neri P. New radioimmunoassay technique using second antibody to solid phase applied to assays of human chorionic somatomammotropin. J Nucl Biol Med. 1973; 17: 14-21.
45. Desbuquois B, Aurbach GD. Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab. 1971; 33: 732-8.
46. Wood WG, Stalla G, Müller OA, Scriba PC. A rapid and specific method for separation of bound and free antigen in radioimmunoassay systems. J Clin Chem Clin Biochem. 1979; 17: 111-4.
47. Ogawa N, Takahara J, Ofuji T. Radioimmunoassay of human growth hormone using ammonium sulphate [in Japanese] Rinsho Byori. 1972; 20: 415-7.
48. Catt K, Niall HD, Tregear GW Solid-phase radioimmunoassay of human growth hormone. Biochem J. 1966; 100: 31-3.
49. Goodfriend T, Ball D, Updike S. Antibody in polyacrylamide gel, a solid phase reagent for radioimmunoassay. Immunochemistry. 1969; 6: 481-4.
50. Eady RP, Chapple JC, Hough DW, Stevenson GT. The specificity of a solid phase radioimmunoassay for human immunoglobulins. J Immunol Methods. 1975; 7: 179-86.
51. Guesdon JL, Thiery R, Avraméas S. Magnetic enzyme immunoassay for measuring human IgE. J Allergy Clin Immunol. 1978; 61: 23-7.
52. Sox HC Jr, Mohit B. Solid-phase radioimmunoassay of protein biosynthesis. Science. 1970; 168: 1467-8.
53. Kalimo KO, Meurman OH, Halonen PE, Ziola BR, Viljanen MK, Granfors K, Toivanen P Solid-phase radioimmunoassay of rubella virus immunoglobulin G and immunoglobulin M antibodies. J Clin Microbiol. 1976; 4: 117-23.
54. Reese MG, Johnson L. Automated measurement of serum thyroxine with the "ARIA II" as compared with competitive protein binding and radioimmunoassay. Clin Chem. 1978; 24: 342-4.
55. Knedel M, Assmann G, Courbe A, van Impe L, Kattermann R, Keller H, Oellerich M, Küppers R, Meyer HD, Willnow P. Investigation of the performance of the ES 600 Enzymun-Test system. A multicentre study. J Clin Chem Clin Biochem. 1988; 26: 149-62.
56. Gallati, VH. Horseradish peroxidase: a study of the kinetics and the determination of optimal reaction conditions, using hydrogen peroxide and 2,2′-azinobis 3-ethylbenzthiazoline-6-sulfonic acid (ABTS) as substrates. J Clin Chem Clin Biochem. 1979; 17: 1-7.
57. Vogeser M, Jacob K. Measurement of free triiodothyronine in intensive care patients-comparison of two routine methods. Eur J Clin Chem Clin Biochem. 1997; 35: 873-5.
58. Reynders M, Anckaert E, Schiettecatte J, Smitz J Evaluation of a new automated electrochemiluminescent sex hormone-binding globulin (SHBG) immunoassay. Clin Chem Lab Med. 2005; 43: 86-9.
59. Fiore M, Mitchell J, Doan T, Nelson R, Winter G, Grandone C, Zeng K, Haraden R, Smith J, Harris K, et al. The Abbott IMx automated benchtop immunochemistry analyzer system. Clin Chem. 1988; 34: 1726-32.
60. Schütz E, Svinarov D, Shipkova M, Niedmann PD, Armstrong VW, Wieland E, Oellerich M. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem. 1998; 44: 2158-64.
61. Kisner HJ. Product development: the making of the Abbott ARCHITECT. Clin Lab Manage Rev. 1997; 11: 419-21.
62. Ognibene A, Drake CJ, Jeng KY, Pascucci TE, Hsu S, Luceri F, Messeri G. A new modular chemiluminescence immunoassay analyser evaluated. Clin Chem Lab Med. 2000; 38: 251-60.
63. Lamb EJ, Noonan KA, Burrin JM. Analytical performance of Immulite assay of thyroid-stimulating hormone. Clin Chem. 1994; 40: 1598-600.
64. Vogeser M, Weigand M, Fraunberger P, Fischer H, Cremer P. Evaluation of the ADVIA Centaur TSH-3 assay. Clin Chem Lab Med. 2000; 38: 331-4.
65. Dasgupta A, Kang E, Datta P. The new enzyme-linked immunosorbent digoxin assay on the ADVIA Integrated Modular System is virtually free from oleander interference. Ther Drug Monit. 2006; 28: 282-5.
66. Laffin RJ, Chan DW, Tanasijevic MJ, Fischer GA, Markus W, Miller J, Matarrese P, Sokoll LJ, Bruzek DJ, Eneman J, Nelson J, Bray KR, Huang J, Loveland KG. Hybritech total and free prostate-specific antigen assays developed for the Beckman Coulter access automated chemiluminescent immunoassay system: a multicenter evaluation of analytical performance. Clin Chem. 2001; 47: 129-32.
67. Costongs GM, Janson PC. Comparison of the automated random access immunoassay analysers, ACS-180 (Ciba Coming) and AIA- 1200 (Tosoh). Eur J Clin Chem Clin Biochem. 1993; 31: 701-6.
68. McAlpine L, Parry JV, Mortimer PP. Anti-HIV testing by automated systems. Clin Diagn Virol. 1993; 1: 225-32.
69. Christenson RH, Demers LM, Goldsmith BM, Noel SA, Duh SH. Performance characteristics of the creatine kinase-MB mass assay on the Vitros ECi analyzer. Clin Biochem. 1999; 32: 237-40.
70. Prontera C, Fortunato A, Storti S, Mercuri A, Longombardo G, Zucchelli GC, Emdin M, Clerico A. Evaluation of analytical performance of the Siemens ADVIA TnI ultra immunoassay. Clin Chem. 2007; 53: 1722-3.
71. Lövgren T, Hemmilä I, Petterson K, Eskola JU, Bertoft E. Determination of hormones by time-resolved fluoroimnmnoassay. Talanta 1984; 31: 909-16.
72. Taïeb J, Sarnel C, Benattar C, Lindenbaum A. Une nouvelle technique de dosage du 17β-estradiol sur le Kryptor® (Cis-Bio international): utilisation au cours des cycles stimulés Ann Biol Clin (Paris). 2000; 58: 71-9.
73. Wøjdemann KR, Larsen SO, Rode L, Shalmi A, Sundberg K, Christiansen M, Tabor A. First trimester Down syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A. Scand J Clin Lab Invest. 2006; 66: 101-11.
74. Kerr JR, Cunniffe VS, Kelleher P, Coats AJ, Mattey DL. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol. 2004; 74: 147-55.
75. Marangoni A, Sparacino M, Mondardini V, Cavrini F, Storni E, Donati M, Cevenini R, Sambri V. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. New Microbiol. 2005; 28: 37-43.
76. Euroimmun Analyser I - For product description and specifications see website: www.euroimmun.de/index.php?id=35&uid=13&L=0#c13.
77. Yamada H, Matsuda S, Ushio Y, Nakamura K, Kobatake S, Satomura S, Matsuura S. Determination of procalcitonin concentration using the SphereLight 180 clinical auto-analyzer. Clin Chim Acta. 2008; 388: 38-40. Epub 2007 Oct 6
78. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephehometer systems (BNA, BN II). Clin Chem. 1997; 43: 1016-22.
79. Mendu DR, Chou PP, Soldin SJ. An improved application for the enzyme multipled immunoassay technique for caffeine, amikacin, and methotrexate assays on the Dade-Behring Dimension RxL Max clinical chemistry system. Ther Drug Monit. 2007; 29: 632-7.
80. Butch AW, Fukuchi AM. Analytical performance of the CEDIA cyclosporine PLUS whole blood immunoassay. J Anal Toxicol. 2004; 28: 204-10.
81. Borque L, Rus A, del Cura J, Maside C, Escanero J. Automated quantitative nephelometric latex immunoassay for determining ferritin in human serum. J Clin Lab Anal. 1992; 6: 239-44.
82. Murphy BE. Radioassays of non-antigenic hormones. Trans Assoc Am Physicians. 1968; 81: 92-103.
83. Reichlin S, Utiger RD. Regulation of the pituitary-thyroid axis in man: relationship of TSH concentration to concentration of free and total thyroxine in plasma. J Clin Endocrinol Metab. 1967; 27: 251-5.
84. Pain RW. In vitro testing of thyroid function: a review. Pathology. 1975; 7: 1-12.
85. Yeo PP, Lewis M, Evered DC. Radioimmunoassay of free thyroid hormone concentrations in the investigation of thyroid disease. Clin Endocrinol (Oxf). 1977; 6: 159-65.
86. Kurtz A, Dwyer K, Ekins R. Serum free thyroxine in pregnancy. Br Med J. 1979; 2(6189): 550-1.
87. Oliver GC Jr, Parker BM, Brasfield DL, Parker CW. The measurement of digitoxin in human serum by radioimmunoassay. J Clin Invest. 1968; 47: 1035-42.
88. Smith TW, Butler VP Jr, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969; 281: 1212-6.
89. Jaffe BM, Smith JW, Newton WT, Parker CW. Radioimmunoassay for prostaglandins. Science. 1971; 171(970): 494-6.
90. Mitchell MD. A sensitive radioimmunoassay for 6-keto-prostaglandin F1alpha: preliminary observations on circulating concentrations. Prostaglandins Med. 1978; 1: 13-21.
91. Frick OL, Ishizaka K. Association of IgE with reaginic activity in sera from grass pollen- and horse dander-sensitive individuals. J Allergy. 1970; 45: 220-33.
92. Ceska M, Eriksson R, Varga JM. Radioimmunosorbent assay of allergens. J Allergy Clin Immunol. 1972; 49: 1-9.
93. Reijula K, Halmepuro L, Hannuksela M, Larmi E, Hassi J. Specific IgE to reindeer epithelium in Finnish reindeer herders. Allergy. 1991; 46: 577-81.
94. Seltzer JM, Halpern GM, Tsay YG. Correlation of allergy test results obtained by IgE FAST, RAST, and prick-puncture methods. Ann Allergy. 1985; 54: 25-30.
95. Pécoud A, Peitrequin R, Fasel J, Frei PC. Comparison of two assays for the determination of specific IgE in serum of atopic and nonatopic subjects: the Allergenetics FAST and the Phadezym RAST. Allergy. 1986; 41: 243-9.
96. Levy M, Gagnadoux MF, Beziau A, Habib R. Membranous ghomerulonephritis associated with anti-tubular and anti-alveolar basement membrane antibodies. Clin Nephrol. 1978; 10: 158-65.
97. Halbert SP, Anken M. Auto-antibodies in infectious mononucleosis, as determined by ELISA. Int Arch Allergy Appl Immunol. 1982;69 (3):257-61.
98. Logtenberg T, Jonker M, Kroon A, Gmelig-Meyling FH, Ballieux RE. Enumeration of (auto)antibody producing cells in human using the "spot-ELISA". Immunol Lett. 1985; 9: 343-7.
99. Engler H, Riesen WF, Keller B. Anti-thyroid peroxidase (anti-TPO) antibodies in thyroid diseases, non-thyroidal illness and controls. Clinical validity of a new commercial method for detection of anti-TPO (thyroid microsomal) autoantibodies. Clin Chim Acta. 1994; 225: 123-36.
100. Navarro E, Bach M, Durán N, Puigdomènech P, Palau J. A multiple sample immunoblotting system (MSIS) for the intrinsic detection of antinuclear autoantibodies. J Immunol Methods. 1986; 91: 75-81.
101. Wood WG, Marschner I, Scriba PC. Rapid and sensitive radioimmunoassays for the c-terminal region of human parathyrin. Fresenius' Z Anal Chem 1978; 290: 170-1.
102. Mallette LE, Coscia AM. Rapid radioimmunoassay for parathyroid hormone: its use in hypercalcemic crisis. South Med J. 1984; 77: 323-6.
103. Wood WG, Kuflicki G, Marschner I, Rapid, sensitive and reproducible assays for human parathyrin. Acta Endocrinol (Kbh) 1978; Suppl. 215: 116-7.
104. Wood WG, Marschner I, Scriba PC. Tests on three antisera and subsequent development of radioimmunoassay for different regions of human parathyrin. Horm Met Res. 1979; 11: 309-17.
105. Brown RC, Aston JP, Weeks I, Woodhead JS. Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab. 1987; 65: 407-14.
106. Sukovaty RL, Lee JW, Fox J, Toney K, Papac DI, Grover TA, Wells DS. Quantification of recombinant human parathyroid hormone (rhPTH(1-84)) in human plasma by immunoassay: commercial kit evaluation and validation to support pharmacokinetic studies. J Pharm Biomed Anal. 2006; 42: 261-71. Epub 2006 Jun 9.
107. Roche Diagnostics News Release - FDA clearance for the 9-minute STAT parathyroid hormone test on the Elecsys 1010 and 2010 systems and cobas e 411 analyser. Indianapolis, 2007-04-23. www.roche-diagnostics.us/ press_room/2007/pr_70659.html
108. Voll R, Schmidt-Gayk H, Wiedeman J, Hüfner M, Bouillon R, Keutmann H, Hehrmann R Radioimmunoassay for parathyrin. Characterization of six different antigens and antisera. J Clin Chem Clin Biochem. 1978; 16: 269-77.
109. Schmidt-Gayk H, Schmitt-Fiebig M, Hitzler W, Armbruster FP, Mayer E. Two homologous radioimmunoassays for parathyrin compared and applied to disorders of calcium metabolism. Clin Chem. 1986; 32: 57-62.
110. Zillikens D, Armbruster FP, Stern J, Schmidt-Gayk H, Raue F. Sensitive homologous radioimmunoassay for human parathyroid hormone to diagnose hypoparathyroid conditions. Ann Clin Biochem. 1987; 24: 608-13.
111. Schneider H, Streicher E, Schmidt-Gayk H, Bosnjakovic S. Does long term haemofiltration provoke secondary hyperparathyroidism? Proc Eur Dial Transplant Assoc. 1978; 15: 532-9.
112. Dunzendorfer U, Ohlenschläger G, Schmidt-Gayk H. Interrelations of PTH, cAMP, creatinine and uric acid in nephrectomized patients under DNA or PTH application. Urol Int. 1980; 35: 328-33.
113. Czernobilsky H, Scharla S, Schmidt-Gayk H, Ziegler R. Enhanced suppression of 1,25(OH)2D3 and intact parathyroid hormone in Graves' disease as compared to toxic nodular goiter. Calcif Tissue Int. 1988; 42: 5-12.
114. Kirch W, Höfig M, Ledendecker T, Schmidt-Gayk H. Parathyroid hormone and cirrhosis of the liver. J Clin Endocrinol Metab. 1990; 71: 1561-6.
115. Reichel H, Liebethal R, Hense HW, Schmidt-Gayk H, Ritz E. Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig. 1992; 70: 748-51.
116. Kokot F, Wiecek A, Schmidt-Gayk H, Marcinkowski W, Gilge U, Heidland A, Rudka R, Trembecki J. Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Artif Organs. 1995; 19: 428-35.
117. Schmidt-Gayk H, Bouillon R, Roth HJ. Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance. Scand J Clin Lab Invest Suppl. 1997; 227: 35-45.
118. Karkoszka H, Chudek J, Strzelczyk P, Wiecek A, Schmidt-Gayk H, Ritz E, Kokot F. Does the vitamin D receptor genotype predict bone mineral loss in haemodialysed patients? Nephrol Dial Transplant. 1998; 13: 2077-80.
119. Woitge HW, Knothe A, Witte K, Schmidt-Gayk H, Ziegler R, Lemmer B, Seibel MJ. Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study. J Bone Miner Res. 2000; 15: 2443-50.
120. Schmidt-Gayk H, Spanuth E, Kötting J, Bartl R, Felsenberg D, Pfeilschifter J, Raue F, Roth HJ. Performance evaluation of automated assays for beta-CrossLaps, N-MID-Osteocalcin and intact parathyroid hormone (BIOROSE Multicenter Study). Clin Chem Lab Med. 2004; 42: 90-5.
121. Reichel H, Roth HJ, Schmidt-Gayk H. Evaluation of serum betacarboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients. Nephron Clin Pract. 2004; 98: c112-8.
122. Schmidt-Gayk H, Blind E, Roth HJ (Eds). Calcium regulating hormones and markers of bone metabolism: Measurement and interpretation., Clin Lab Publications, Heidelberg, 1997; 2nd Edition: 209 pages - ISBN 3-9805785-0-X
123. Ekins R. Immunoassay standardization. Scand J Clin Lab Invest Suppl. 1991; 205: 33-46.
124. Rastel D, Ramaioli A, Cornillie F, Thirion B. CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group. Eur J Cancer. 1994; 30A: 601-6.
125. Hattori N, Kitagawa K, Inagaki C Human lymphocytes express hGH-N gene transcripts of 22kDa, 20kDa and minor forms of GH, but not hGH-V gene. Eur J Endocrinol. 1999; 141: 413-8.
126. Momomura S, Hashimoto Y, Shimazaki Y, Irie M Detection of exogenous growth hormone (GH) administration by monitoring ratio of 20kDa- and 22kDa-GH in serum and urine. Endocr J. 2000; 47: 97-101.
127. Bidlingmaier M, Strasburger CJ. Technology insight: detecting growth hormone abuse in athletes. Nat Clin Pract Endocrinol Metab. 2007; 3: 769-77.
128. Laessig D, Nagel D, Heinemann V, Untch M, Kahlert S, Bauerfeind I, Stieber P. Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients. Anticancer Res. 2007; 27(4A): 1963-8.
129. Stieber P, Heinemann V, Schalhorn A. Tumor-Marker: Wie sollten sie angewendet werden? MMW Fortschr Med. 2005; 147: 35-9.
130. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal L 331, 7.12.1998, 1-40.
131. Inventory of External QA Programs for Clinical (Medical) Laboratories. World wide directory on the internet, website address: http://wwwn.cdc.gov/mlp/EQA_programs.aspx.
132. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen gemäß Beschluss des Vorstandes der Bundesärztekammer vom 23. November 2007. Deutsches Ärztebl. 2008; 105: A341-55.
133. UK-NEQAS - United Kingdom National External Quality Assessment Service. Website: http://www.ukneqas.org.uk/content/Pageserver.asp.
134. SKML - Stichting Kwaliteitsbewaking Medische Laboratorium-diagnostiek, The Netherlands, website: http://www.skml.nl/.
135. QUALAB - Schweizerische Kommission für Qualitätssicherung im medizinischen Labor; Commission suisse pour l'assurance qualité dans le laboratoire médical; Commissione svizzera per l'assicurazione di qualità nel laboratorio medico; website: http://www.qualab.ch/
136. AFSSAPS - Agence Française de Sécurité SAnitaire des Produits de Santé website: http://agmed.sante.gouv.fr/htm/ 10/cnq/indcnq.htm
137. Wood, WG. "Matrix effects" in immunoassays. Scand J Clin Invest. 1991; 51: Suppl. 205, 105-12.
138. Stöckl D, Libeer JC, Reinauer H, Thienpont LM, De Leenheer AP. Accuracy-based assessment of proficiency testing results with serum from single donations: possibilities and limitations. Clin Chem. 1996; 42: 469-70.
139. Thienpont LM, Stöckl D, Friedecký B, Kratochvíla J, Budina M. Trueness verification in European external quality assessment schemes: time to care about the quality of the samples. Scand J Clin Lab Invest. 2003; 63: 195-201.
140. Wood WG. Sample commutability in external quality assessment surveys (EQAS) for thyroid-related antibodies-state of the art. Clin Lab. 2007; 53: 217-22.
141. Ceglarek U, Lembcke J, Fiedler GM, Werner M, Witzigmann H, Hauss JP, Thiery J. Rapid simultaneous quantification of immunosuppressants in transplant patients by turbulent flow chromatography combined with tandem mass spectrometry. Clin Chim Acta. 2004; 346: 181-90.
142. Ceglarek U, Casetta B, Lembcke J, Baumann S, Fiedler GM, Thiery J. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants. Clin Chim Acta. 2006; 373: 168-71. Epub 2006 May 17.
143. Darby SM, Miller ML, Allen RO, LeBeau M. A mass spectrometric method for quantitation of intact insulin in blood samples. J Anal Toxicol. 2001; 25: 8-14.
144. Rogatsky E, Balent B, Goswami G, Tomuta V, Jayatillake H, Cruikshank G, Vele L, Stein DT. Sensitive quantitative analysis of C-peptide in human plasma by 2-dimensional liquid chromatography-mass spectrometry isotope-dilution assay. Clin Chem. 2006; 52: 872-9. Epub 2006 Mar 23.
145. Murphy EA, Rowsell HC, Mustard JF. The effects of sitosterol on serum cholesterol, platelet economy, thrombogenesis and atherosclerosis in the rabbit. Atherosclerosis. 1973; 17: 257-68.
146. Salen G, Horak I, Rothkopf M, Cohen JL, Speck J, Tint GS, Shore V, Dayal B, Chen T, Shefer S. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J Lipid Res. 1985; 26: 1126-33.
147. Parsons M, Newman DJ, Pugia M, Newall RG, Price CP. Performance of a reagent strip device for quantitation of the urine albumin: creatinine ratio in a point of care setting. Clin Nephrol. 1999; 51: 220-7.
148. Zuiderwijk M, Tanke HJ, Sam Niedbala R, Corstjens PL. An amplification-free hybridization-based DNA assay to detect Streptococcus pneumoniae utilizing the up-converting phosphor technology. Clin Biochem. 2003; 36: 401-3.
149. Thomas LJ, Bessman SP. Prototype for an implantable insulin delivery pump. Proc West Pharmacol Soc. 1975; 18: 393-8.
150. Brückel J, Kerner W, Zier H, Steinbach G, Pfeiffer EF. In vivo measurement of subcutaneous glucose concentrations with an enzymatic glucose sensor and a wick method. Klin Wochenschr. 1989; 67: 491-5.
151. Sreenivasan K. Detection of creatinine enriched on a surface imprinted polystyrene film using FT-ATR-IR. J Mol Recognit. 2006 Sep-Oct;19(5):408-12
152. Kaushal N, Sanyal SN. Modulations in the intestinal disaccharide hydrolases and membrane dynamics: effect of non-steroidal anti-inflammatory drugs aspirin and nimesulide. Mol Cell Biochem. 2007; 294: 107-15. Epub 2006 Jul 20
153. Rouahi M, Gallet O, Champion E, Dentzer J, Hardouin P, Anselme K. Influence of hydroxyapatite microstructure on human bone cell response. J Biomed Mater Res A. 2006; 78: 222-35.
154. Goodacre R, Timmins EM, Burton R, Kaderbhai N, Woodward AM, Kell DB, Rooney PJ. Rapid identification of urinary tract infection bacteria using hyperspectral whole-organism finger-printing and artificial neural networks. Microbiology. 1998; 144:1157-70.
155. Shichiri M, Nishida K, Uemura T. [Measurement of blood glucose concentration using infra-red spectroscopy] Nippon Rinsho. 1997; 55 Suppl: 895-9.
156. Kajiwara K, Uemura T, Kishikawa H, Nishida K, Hashiguchi Y, Uehara M, Sakakida M, Ichinose K, Shichiri M. Noninvasive measurement of blood glucose concentrations by analysing Fourier transform infra-red absorbance spectra through oral mucosa. Med Biol Eng Comput. 1993; 31 Suppl:S17-22.
157. Barraud A, Perrot H, Billard V, Martelet C, Therasse J. Study of immunoglobulin G thin layers obtained by the Langmuir-Blodgett method: application to immunosensors. Biosens Bio-electron. 1993; 8: 39-48.
158. Ehrmeyer SS, Laessig RH. Point-of-care testing, medical error, and patient safety: a 2007 assessment. Clin Chem Lab Med. 2007; 45: 766-73.
159. Scalise D. Poised for growth. Point-of-care testing. Hosp Health Netw. 2006; 80: 77-83. (Erratum in: Hosp Health Netw. 2006; 80: 10).
160. Lehmann CA. The future of home testing-implications for traditional laboratories. Clin Chim Acta. 2002; 323: 31-6.
161. Bush DM. The U.S. Mandatory Guidelines for Federal Workplace Drug Testing Programs: current status and future considerations. Forensic Sci Int. 2008; 174: 111-9. Epub 2007 Apr 16.
162. Nichols JH, Christenson RH, Clarke W, Gronowski A, Hammett-Stabler CA, Jacobs E, Kazmierczak S, Lewandrowski K, Price C, Sacks DB, Sautter RL, Shipp G, Sokoll L, Watson ID, Winter W, Zucker ML; National Academy of Clinical Biochemistry. Executive summary. The National Academy of Clinical Biochemistry Laboratory Medicine Practice Guideline: evidence-based practice for point-of-care testing. Clin Chim Acta. 2007; 379: 14-28; discussion 29-30. Epub 2007 Jan 12. (Comment in: Clin Chim Acta. 2007; 381: 184-5; author reply 186-7).
163. Shephard MD, Mazzachi BC, Shephard AK, McLaughlin KJ, Denner B, Barnes G. The impact of point of care testing on diabetes services along Victoria's Mallee Track: results of a community-based diabetes risk assessment and management program. Rural Remote Health. 2005; 5: 371. Epub 2005 Jul 15.
164. von Lode P. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin Biochem. 2005; 38: 591-606.
165. Oh SW, Moon JD, Park SY, Jang HJ, Kim JH, Nahm KB, Choi EY. Evaluation of fluorescence hs-CRP immunoassay for point-of-care testing. Clin Chim Acta. 2005; 356: 172-7. Epub 2005 Mar 31.
166. Bissell M, Sanfilippo F. Empowering patients with point-of-care testing. Trends Biotechnol. 2002; 20: 269-70.